Erasca director granted options on 29,888 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca, Inc. director Julie Hambleton reported receiving a stock option grant as part of her compensation. She was awarded options covering 29,888 shares of common stock at an exercise price of $16.01 per share. These options vest 100% on June 26, 2027, provided she continues serving the company through that date, and expire on June 26, 2036. Following this grant, she holds stock options for 29,888 shares directly. This is a compensation-related award rather than an open-market purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 29,888 | $0.00 | $0.00 |
Footnotes (1)
- F1. 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date.
Key Figures
Key Terms
Stock option (right to buy) financial
exercise price financial
expiration date financial
underlying security financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Erasca (ERAS) director Julie Hambleton report on this Form 4?
What is the exercise price of Julie Hambleton’s Erasca (ERAS) stock options?
When do Julie Hambleton’s Erasca (ERAS) stock options vest and expire?
Is Julie Hambleton buying or selling Erasca (ERAS) stock in this Form 4?
How many Erasca (ERAS) stock options does Julie Hambleton hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.